Position in IRWD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$894,940
+$480,091 QoQ
Shares Held
212,575
+79.9% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 212 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. IRWD ranks #33 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in IRWD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $894,940 | 212,575 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $414,849 | 118,191 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $723,224 | 214,607 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $146,925 | 112,157 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $81,563 | 113,284 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,502,868 | 1,702,633 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $4,760,060 | 1,074,506 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,264,281 | 306,865 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $12,081,589 | 1,853,005 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $10,323,307 | 1,185,225 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $16,643,837 | 1,454,881 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $4,634,965 | 481,305 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $13,730,077 | 1,290,421 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $6,681,334 | 635,108 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $24,639,084 | 1,988,627 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,020,899 | 581,168 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,271,665 | 717,404 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $9,973,421 | 792,800 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $14,888,745 | 1,276,908 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $23,067,798 | 1,766,294 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $11,872,148 | 922,467 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $12,966,283 | 1,159,775 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $5,748,315 | 504,681 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $742,833 | 82,629 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $832,347 | 80,654 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $1,184,564 | 117,400 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||